false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
Member Special - Improving Patient Care
Lipid Management in Patients with Endocrine Disord ...
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This video was a session on lipid management in patients with endocrine disorders, presented by the Endocrine Society. The session was led by Dr. Patrick McBride, an emeritus professor of medicine at the University of Wisconsin School of Medicine and Public Health, and featured a panel of distinguished experts in the field. The session aimed to provide an overview of the Endocrine Society's clinical practice guidelines for lipid management in patients with endocrine disorders.<br /><br />The session began with an introduction from Dr. McBride, who provided information on where to find the guideline and associated resources. The panelists were introduced, including Dr. Connie Newman, Dr. Ira Goldberg, Dr. Alan Chait, and Dr. Lisa Tanik. The panelists shared their expertise on various endocrine disorders and lipid management.<br /><br />The first patient case discussed was a 32-year-old woman with type 2 diabetes. The panel discussed the importance of early statin therapy in patients with type 2 diabetes and cardiovascular risk factors. The panel also addressed concerns about the age of the patient and the use of statins in younger individuals. They emphasized the strong evidence supporting the use of statins in patients with diabetes to reduce cardiovascular risk.<br /><br />The second patient case discussed was a 52-year-old woman with severe hypertriglyceridemia and acute pancreatitis. The panel highlighted the risk of pancreatitis in patients with very high triglyceride levels and the importance of triglyceride-lowering therapy, such as fibrates, in these patients. They also touched on the interaction between fibrates and statins and the need for cautious use of these medications in combination.<br /><br />The final patient case discussed was a 62-year-old woman with subclinical hypothyroidism. The panel debated the use of thyroid hormone replacement therapy in patients with elevated TSH levels and the impact of treatment on lipid levels. They also mentioned the importance of evaluating thyroid antibodies and ultrasound findings in determining the cause of subclinical hypothyroidism.<br /><br />Throughout the session, the panel emphasized the importance of treating lipid disorders in patients with endocrine disorders to reduce cardiovascular risk. They provided evidence-based recommendations for lipid management in these patients, including the use of statins, fibrates, and thyroid hormone replacement therapy.<br /><br />Overall, the session provided valuable insights into the management of lipid disorders in patients with endocrine disorders and highlighted the importance of individualized treatment based on patient characteristics and risk factors. No specific credits were granted in the video.
Keywords
lipid management
endocrine disorders
Endocrine Society
Dr. Patrick McBride
clinical practice guidelines
statin therapy
type 2 diabetes
cardiovascular risk
hypertriglyceridemia
fibrates
×